Hypertension Clinical Trial
Official title:
An Intervention to Increase Engagement With Hypertension Care for American Indian Patients
The objective of this study is to reduce the effects of stereotype threat on the adherence of
American Indian/Alaska Native patients with hypertension.
The specific aims of this study, which employs a values affirmation intervention, are to:
1. Compare the effects of the values-affirmation exercise with a control exercise in AI/AN
patients with hypertension.
2. Compare the effects of the values-affirmation exercise in AI/AN patients with its
effects in white patients.
American Indians and Alaska Natives (AI/ANs) in the U.S. bear a disproportionate burden of
cardiovascular disease. They have a higher prevalence of conditions that predispose to
cardiovascular disease and poorer outcomes after developing cardiovascular disease than white
Americans. The causes of these differences are complex and multiple, but there are widespread
concerns that racial bias contributes to the problem. As concluded over a decade ago in the
2003 Institute of Medicine report, Unequal Treatment, "Racial/ethnic disparities in health
care occur in the context of broader historic and contemporary social and economic inequality
and evidence of persistent racial and ethnic discrimination… Bias, stereotyping and prejudice
on the part of healthcare providers may contribute to racial and ethnic disparities in health
care." These concerns persist. Minority group members are well aware of negative stereotypes
targeted at them as a group and of the possibility of bias directed at them as individuals.
Given the reality of prejudice and their previous experiences with it, it is understandable
that minority group members would be apprehensive about the possibility of being judged in
light of the stereotype, both outside and inside the healthcare system. Critically, this
apprehension may occur in the absence of actual bias. This raises the possibility that
interventions directed at patients' perception of discrimination may have an independent and
additive effect beyond the effects of interventions directed at provider bias.
Investigators propose to evaluate a novel intervention that reduces the detrimental effects
of negative stereotypes on minority patients by reducing stereotype threat through values-
affirmation. Stereotype threat is a stressful psychological state that occurs when a person
fears being judged in light of negative stereotypes. The stress of this situation and the
pressure to avoid confirming negative stereotypes can result in impaired performance and
worse outcomes - something of a self-fulfilling prophecy. For example, an American Indian
patient fearful of confirming the stereotype of being unintelligent may fail to ask for
clarification of changes in antihypertensive medications and, based on misconceptions,
persist in taking an old regimen that is ineffective. Values-affirmation is a process in
which global sense of personal worth is strengthened in the face of a threat, making
individuals better able to cope with psychological threats.
The intervention proposed in this application is based on one found to be effective in
alleviating stereotype threat in other contexts such as education and in alleviating more
general threats to the self in a health context as well as in a prior study investigators
performed with African American patients. Investigators will randomly assign AI/AN patients
with hypertension to complete an affirmation exercise or a control exercise prior to a visit
with their providers. The affirmation exercise is performed immediately before a clinic
visit. It asks patients to reflect on values or self-defining skills that they find
important, and to write a few sentences about why one of them is important. The project is
innovative in that it is directed against a mechanism, stereotype threat, not generally
recognized as important in healthcare settings. Since the intervention is brief and easily
applied across a wide range of health conditions, it directly addresses the need for
interventions to be generalizable and sustainable.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT04591808 -
Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia
|
Phase 3 | |
Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
Completed |
NCT05433233 -
Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension
|
N/A | |
Completed |
NCT05491642 -
A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single and Multiple Doses
|
Phase 1 | |
Completed |
NCT03093532 -
A Hypertension Emergency Department Intervention Aimed at Decreasing Disparities
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Completed |
NCT05529147 -
The Effects of Medication Induced Blood Pressure Reduction on Cerebral Hemodynamics in Hypertensive Frail Elderly
|
||
Recruiting |
NCT05976230 -
Special Drug Use Surveillance of Entresto Tablets (Hypertension)
|
||
Recruiting |
NCT06363097 -
Urinary Uromodulin, Dietary Sodium Intake and Ambulatory Blood Pressure in Patients With Chronic Kidney Disease
|
||
Completed |
NCT06008015 -
A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1015" and Co-administration of "BR1015-1" and "BR1015-2" Under Fed Conditions in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT05387174 -
Nursing Intervention in Two Risk Factors of the Metabolic Syndrome and Quality of Life in the Climacteric Period
|
N/A | |
Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
Recruiting |
NCT05121337 -
Groceries for Black Residents of Boston to Stop Hypertension Among Adults Without Treated Hypertension
|
N/A | |
Withdrawn |
NCT04922424 -
Mechanisms and Interventions to Address Cardiovascular Risk of Gender-affirming Hormone Therapy in Trans Men
|
Phase 1 | |
Active, not recruiting |
NCT05062161 -
Sleep Duration and Blood Pressure During Sleep
|
N/A | |
Not yet recruiting |
NCT05038774 -
Educational Intervention for Hypertension Management
|
N/A | |
Completed |
NCT05087290 -
LOnger-term Effects of COVID-19 INfection on Blood Vessels And Blood pRessure (LOCHINVAR)
|
||
Completed |
NCT05621694 -
Exploring Oxytocin Response to Meditative Movement
|
N/A | |
Completed |
NCT05688917 -
Green Coffee Effect on Metabolic Syndrome
|
N/A | |
Recruiting |
NCT05575453 -
OPTIMA-BP: Empowering PaTients in MAnaging Blood Pressure
|
N/A |